All In Biotech

Drug Trial Radar · NCT07822061

AMAZE 10: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People in Japan With Excess Body Weight Lose Weight

Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Japanese Participants With Overweight or Obesity (AMAZE 10)

Last checked: Nov 20, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Sep 7, 2026

Primary completion

Feb 5, 2029

Study completion Feb 5, 2029

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Sep 16, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people with excess body weight and to compare its effects with placebo. Participants will receive either NNC0487-0111, the treatment being tested, or placebo, a treatment with no active medicine. Which treatment participants receive is decided by chance. NNC0487-0111 is a new medicine that doctors cannot yet prescribe, but it has been tested in humans before.

Conditions

  • Overweight
  • Obesity

Interventions

  • NNC0487-0111Drug

    NNC0487-0111 will be administered subcutaneously using PDS290 pre-filled pen injectors to one of the body parts: thigh, abdomen or upper arm.

  • Placebo (matched to NNC0487-0111)Drug

    Placebo matched to NNC0487-0111 will be administered subcutaneously using pre- filled pen-injectors to one of the body parts: thigh, abdomen or upper arm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Relative change in body weightTime frame: From baseline (week 0) to week 84

Locations

26 sites in 1 country. Site status is shown where the registry gives one.

  • TOSAKI Clinic for Diabetes and Endocrinology_Diabetes and Endocrinology

    Aichi, Japan · Recruiting

  • The University of Tokyo Hospital, Diabetes and Metabolic

    Bunkyo-ku, Tokyo, Japan · Not yet recruiting

  • Tokuyama clinic_Diabetic internal medicine

    Chiba, Japan · Not yet recruiting

  • Akaicho Clinic_Internal medicine

    Chiba-shi, Chiba, Japan · Recruiting

  • Suidoubashi Medical Clinic_Internal Medicine

    Chiyoda-ku, Tokyo, Japan · Recruiting

  • Tokyo Asbo Clinic_Internal Medicine

    Chuo-ku, Tokyo, Japan · Recruiting

  • Kuroda Orthopedic Clinic_Orthopedic Surgery and Internal Medicine

    Fukuoka-shi, Fukuoka, Japan · Recruiting

  • Naka Kinen Clinic_Internal medicine

    Ibaraki, Japan · Recruiting

  • Iwamoto Internal Medicine Clinic_Diabetes Internal Medicine

    Kagawa, Japan · Recruiting

  • Takai Internal Medicine Clinic_Internal Medicine

    Kamakura-shi, Kanagawa, Japan · Recruiting

  • Motomachi Takatsuka Naika Clinic_Internal Medicine

    Kanagawa, Japan · Not yet recruiting

  • Yokohama Minoru Clinic_Internal medicine

    Kanagawa, Japan · Not yet recruiting

  • JCHO Kyushu Hospital_Department of Endocrinology and Metabolism

    Kitakyushu-shi, Fukuoka, Japan · Not yet recruiting

  • Seino Internal Medicine Clinic_Internal medicine

    Koriyama-shi, Fukushima, Japan · Recruiting

  • National Hospital Organization Kyoto Medical Center_Diabetic Center

    Kyoto-shi, Kyoto, Japan · Not yet recruiting

  • The University of Osaka Hospital_Metabolic Medicine

    Osaka, Japan · Recruiting

  • Morimoto Clinic_Pain Clinic

    Osaka-shi, Osaka, Japan · Not yet recruiting

  • Tokyo-Eki Center-building Clinic_Internal Medicine

    Tokyo, Japan · Not yet recruiting

  • Clinical Research Hospital Tokyo_Internal medicine

    Tokyo, Japan · Recruiting

  • ToCROM Clinic_Internal Medicine

    Tokyo, Japan · Recruiting

  • Yao Tokushukai General Hospital_Internal medicine

    Yao City, Osaka, Japan · Recruiting

  • Shinsapporo Seiryou Hospital_General Clinical Department

    Sapporo, Hokkaido, Japan · Recruiting

  • Tsuruma Kaneshiro Diabetes Clinic_Internal medicine

    Yamato-shi, Kanagawa, Japan · Not yet recruiting

  • Hayashi Diabetes Clinic_Internal Medicine and Diabetes Medicine

    Chigasaki-shi, Kanagawa, Japan, Japan · Recruiting

  • Matsuba Clinic_Internal Medicine

    Kawasaki-shi, Kanagawa, Japan, Japan · Not yet recruiting

  • OCROM Clinic_Internal medicine

    Suita-shi, Osaka, Japan · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.